Control of Shivering During Targeted Temperature Management
- PMID: 32084066
- DOI: 10.1097/CNQ.0000000000000305
Control of Shivering During Targeted Temperature Management
Abstract
Targeted temperature management (TTM) is used frequently in patients with a variety of diseases, especially those who have experienced brain injury and/or cardiac arrest. Shivering is one of the main adverse effects of TTM that can often limit its implementation and efficacy. Shivering is the body's natural response to hypothermia and its deleterious effects can negate the benefits of TTM. The purpose of this article is to provide an overview of TTM strategies and shivering management.
References
-
- Madden LK, Hill M, May TL, et al. The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society. Neurocrit Care. 2017;27(3):468–487. doi:10.1007/s12028-017-0469-5.
-
- Benson DW, Williams GR, Spencer FC, Yates AJ. The use of hypothermia after cardiac arrest. Anesth Analg. 1959;38(6):423.
-
- Rosomoff HL. Hypothermia in management of cerebrovascular lesions. South Med J. 1961;54:498–505. doi:10.1097/00007611-196105000-00006.
-
- Lemiale V, Huet O, Vigué B, et al. Changes in cerebral blood flow and oxygen extraction during post-resuscitation syndrome. Resuscitation. 2008;76(1):17–24. doi:10.1016/j.resuscitation.2007.06.028.
-
- Rosomoff HL, Holaday DA. Cerebral blood flow and cerebral oxygen consumption during hypothermia. Am J Physiol. 1954;179(1):85–88. doi:10.1152/ajplegacy.1954.179.1.85.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical